NO20000894L - Transdermalt terapeutisk system med aktiv substans av Scopolamin base - Google Patents

Transdermalt terapeutisk system med aktiv substans av Scopolamin base

Info

Publication number
NO20000894L
NO20000894L NO20000894A NO20000894A NO20000894L NO 20000894 L NO20000894 L NO 20000894L NO 20000894 A NO20000894 A NO 20000894A NO 20000894 A NO20000894 A NO 20000894A NO 20000894 L NO20000894 L NO 20000894L
Authority
NO
Norway
Prior art keywords
active substance
transdermal therapeutic
therapeutic system
scopolamine base
base
Prior art date
Application number
NO20000894A
Other languages
English (en)
Other versions
NO20000894D0 (no
Inventor
Walter Mueller
Original Assignee
Lohmann Therapie Syst Lts Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts Ag filed Critical Lohmann Therapie Syst Lts Ag
Publication of NO20000894D0 publication Critical patent/NO20000894D0/no
Publication of NO20000894L publication Critical patent/NO20000894L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Abstract

Et transdermalt terapeutisk system med virkestoffet scopolaminbase, omfattende et fleksibelt baksjikt som er ugjennomtrengelig for virkestoffet, et virkestoffholdig reservoarsjikt, en styringsmembran, et klebesjikt for festing av systemet på huden, så vel som en beskyttelsesfolie som er ugjennomtrengelig for virkestoffet, og som kan fjernes før påføring, er kjennetegnet ved - at reservoarsjiktet så vel som klebesjiktet består av en selvklebende aminresistent silikonpolymer som basispolymer, - at styringsmembranen består av en etylen-yinylacetat-copolymer, og - at scopolaminbasen til dels minst foreligger i reservoarsjiktet i krystallinsk form.
NO20000894A 1997-09-04 2000-02-23 Transdermalt terapeutisk system med aktiv substans av Scopolamin base NO20000894L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19738643A DE19738643C2 (de) 1997-09-04 1997-09-04 Transdermales therapeutisches System mit dem Wirkstoff Scopolaminbase und Verfahren zu seiner Herstellung
PCT/EP1998/005224 WO1999011265A1 (de) 1997-09-04 1998-08-18 Transdermales therapeutisches system mit dem wirkstoff scopolaminbase

Publications (2)

Publication Number Publication Date
NO20000894D0 NO20000894D0 (no) 2000-02-23
NO20000894L true NO20000894L (no) 2000-02-23

Family

ID=7841162

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000894A NO20000894L (no) 1997-09-04 2000-02-23 Transdermalt terapeutisk system med aktiv substans av Scopolamin base

Country Status (22)

Country Link
US (1) US6537571B1 (no)
EP (1) EP1011674B1 (no)
JP (1) JP3834202B2 (no)
KR (1) KR100549846B1 (no)
AT (1) ATE214606T1 (no)
AU (1) AU738009B2 (no)
CA (1) CA2300339C (no)
DE (2) DE19738643C2 (no)
DK (1) DK1011674T3 (no)
ES (1) ES2174492T3 (no)
HK (1) HK1032194A1 (no)
HU (1) HUP0003480A3 (no)
ID (1) ID24266A (no)
IL (1) IL134418A (no)
NO (1) NO20000894L (no)
NZ (1) NZ502873A (no)
PL (1) PL339226A1 (no)
PT (1) PT1011674E (no)
SK (1) SK3052000A3 (no)
TR (1) TR200000407T2 (no)
WO (1) WO1999011265A1 (no)
ZA (1) ZA988052B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050013957A1 (en) * 2003-07-15 2005-01-20 Boris Leschinsky Disposable medical article with multiple adhesives for skin attachment
DE102004020463A1 (de) * 2004-04-26 2005-11-10 Grünenthal GmbH Wirkstoffabgabesystem aus einem wirkstoffhaltigen Pflaster und mindestens einem Wirkstoffabgaberegulierungsmittel
DE102004044578A1 (de) 2004-09-13 2006-03-30 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit einer Haftschicht, Verfahren zum Silikonisieren einer Rückschicht des Systems und Verwendung der Rückschicht
US20070010550A1 (en) * 2005-07-08 2007-01-11 The Board Of Regents Of The University Of Texas Scopolamine to Reduce or Eliminate Hot Flashes, Night Sweats, and Insomnia
US8715723B2 (en) * 2006-02-27 2014-05-06 Noven Pharmaceuticals, Inc. Compositions and methods for delivery of amino-functional drugs
DE102006054732B4 (de) * 2006-11-21 2010-12-30 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit Ionenpaar-Mikroreservoiren
KR101572721B1 (ko) 2013-10-14 2015-11-27 주식회사 엘지생활건강 히오신을 유효 성분으로 함유하는 피부 건조증 또는 피부 장벽 기능 개선용 조성물
CN107708678A (zh) * 2015-04-14 2018-02-16 阿托萨遗传学公司 治疗乳房病症以及雌激素相关病症的组合物和方法
BR112019023393A2 (pt) * 2017-06-26 2020-06-16 Lts Lohmann Therapie-Systeme Ag Sistema terapêutico transdérmico contendo escopolamina e polímero híbrido de acrílico e silicone
DE102018118507A1 (de) 2018-07-31 2020-02-06 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Abgabe von Scopolamin ohne Membran

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US35474A (en) * 1862-06-03 Improved rocket-harpoon
US3797494A (en) * 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
US3903880A (en) * 1972-08-17 1975-09-09 Alza Corp Intrauterine device for managing the reproductive process
US4573996A (en) * 1984-01-03 1986-03-04 Jonergin, Inc. Device for the administration of an active agent to the skin or mucosa
US4655767A (en) * 1984-10-29 1987-04-07 Dow Corning Corporation Transdermal drug delivery devices with amine-resistant silicone adhesives
US4832953A (en) 1987-08-13 1989-05-23 Alza Corporation Method for preventing the formation of a crystalline hydrate in a dispersion of a liquid in a monaqueous matrix
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
DE3908431A1 (de) * 1989-03-15 1990-09-27 Lohmann Therapie Syst Lts Transdermales system mit gestufter wirkstoffabgabe und verwendung fuer die lokale oder systemische wirkstoffverabreichung
CA2150370C (en) * 1993-09-30 2002-03-26 Yasuo Shikinami Transdermal absorption preparation
DE4438989C2 (de) * 1994-09-16 1999-02-25 Lohmann Therapie Syst Lts Scopolaminpflaster
US5714162A (en) * 1994-09-16 1998-02-03 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Scopolamine patch
WO1997020550A2 (en) 1995-12-01 1997-06-12 Alza Corporation Improved method for preventing crystal formation in a dispersion of a liquid in a matrix

Also Published As

Publication number Publication date
ID24266A (id) 2000-07-13
DE19738643C2 (de) 2001-10-04
EP1011674B1 (de) 2002-03-20
HK1032194A1 (en) 2001-07-13
JP3834202B2 (ja) 2006-10-18
NZ502873A (en) 2001-07-27
TR200000407T2 (tr) 2000-08-21
SK3052000A3 (en) 2000-12-11
KR100549846B1 (ko) 2006-02-06
AU738009B2 (en) 2001-09-06
CA2300339C (en) 2007-07-17
ZA988052B (en) 1999-03-05
KR20010023647A (ko) 2001-03-26
US6537571B1 (en) 2003-03-25
IL134418A0 (en) 2001-04-30
DE19738643A1 (de) 1999-03-11
JP2001514226A (ja) 2001-09-11
ES2174492T3 (es) 2002-11-01
WO1999011265A1 (de) 1999-03-11
ATE214606T1 (de) 2002-04-15
PL339226A1 (en) 2000-12-04
EP1011674A1 (de) 2000-06-28
PT1011674E (pt) 2002-08-30
DK1011674T3 (da) 2002-07-08
AU9343498A (en) 1999-03-22
CA2300339A1 (en) 1999-03-11
HUP0003480A3 (en) 2001-03-28
IL134418A (en) 2004-02-19
NO20000894D0 (no) 2000-02-23
HUP0003480A2 (hu) 2001-02-28
DE59803454D1 (de) 2002-04-25

Similar Documents

Publication Publication Date Title
CA2153572A1 (en) Transdermal therapeutic system with galanthamine as active ingredient
CA2030178A1 (en) Transdermal therapeutic system comprising as active component buprenorphine
JPS6468314A (en) Transdermal drug administration system containing two kind of permeation accelerators
ES8801987A1 (es) Metodo de fabricacion de un dispositivo medico para la administracion de una droga insoluble en grasas, altamente ionizadas.
NO20050472L (no) Forbedret transdermalt leveringssystem for administrering av rotigotin
SI1009393T1 (en) Transdermal therapeutic system comprising a reservoir-type pressure-sensitive adhesive layer and a back layer with uni-directional resilience
HUP0401512A2 (hu) Hatóanyagként fentanilt tartalmazó transzdermális gyógyászati rendszer
ATE396714T1 (de) Transdermales therapeutisches system mit verbessertem langzeittragekomfort
NO20000894L (no) Transdermalt terapeutisk system med aktiv substans av Scopolamin base
CA2338859A1 (en) Estradiol-containing patch for transdermal administration of hormones
NZ509215A (en) Transdermal plaster preparation containing at least one active ingredient which influences blood serum lipid levels
AU2108300A (en) Transdermal therapeutic system with self-adhesive matrix, containing organic acid addition salts of morphine- or morphinan-type alkaloids
JP2005520844A (ja) 別々に分離できる経皮治療システムからなる組立ユニット
WO1994025025A3 (de) Systeme zur kontrollierten abgabe von pilocarpin
HUP0003347A2 (hu) Transzdermális terápiás rendszer (TTS) hatóanyag leadásához és eljárás a bőrre történő alkalmazáshoz
MD937C2 (ro) Sistem terapeutic transdermal pentru aplicarea cutanală a fizostigminei pe piele şi procedeu de obţinere a lui

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application